Showing 10 articles tagged 'MRI':
Plans to rollout mpMRI scans before a first biopsy for all UK men suspected of prostate cancer are under threat, as long-term vacancies and increasing demand put a strain on the NHS's radiology services.
After today's confirmation that mpMRI scans before a biopsy can radically improve the accuracy of prostate cancer diagnosis, figures reveal that just 32% of eligible men currently have access to the procedure because of a shortage of scanners and qualified staff to use them in the NHS.
BLOG: Today's announcement about mpMRI scans before a biopsy is a game-changer for prostate cancer diagnosis. But without Prostate Cancer UK's funding of a pilot project in 2010 thanks to your donations, this ground-breaking research would never have happened, says Dr Ian Le Guillou.
BLOG: We're only 12 months into our ten-year strategy to tame prostate cancer, but that doesn't mean we haven't already made exciting progress. Our resident expert, Dr Ian Le Guillou, gives us his top ten biggest research breakthroughs (in no particular order) from 2016.
Preliminary results from the PROMIS trial announced in Chicago today show using mpMRI before a biopsy could reduce the number of men having unnecessary invasive tests for prostate cancer.
BLOG: From training up radiologists to working alongside commissioners and the NHS, Dr Sophie Lutter explains how we're making sure the results of the PROMIS trial are rolled out into real-life hospitals as soon as they've been peer-reviewed, and why rushing it could do more harm than good.
BLOG: Sophie Lutter explains what we're doing to improve the availability of PSA testing to men who want or need it and why, on its own, it's still not the answer to creating a national screening programme for prostate cancer.
The University College Hospital Urology Team recently won an award for their pioneering improvements to prostate cancer diagnosis. We find out how two of them now hope to raise £1 million for us on an epic cycle ride and what makes the team's work so exciting.
One of the big questions in prostate cancer research is how can we diagnose prostate cancer better? We've awarded grants to two new clinical trials working to improve diagnosis through refining imaging technology. Sound familiar? That's because these trials are part of a growing wave of research in this area and things are moving fast.
Can a new form of imaging, called multiparametric (mp) MRI, help doctors make sure they don’t miss life-threatening prostate cancer and help men avoid unnecessary biopsies? We investigate and speak to the experts.